Miguel R Arguedas - Brollo, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 121 Medical Center Dr, Suite 3400, Brunswick, ME 04011 Phone: 207-406-7300 Fax: 207-406-7301 |
Gary Zartarian, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 121 Medical Center Dr, Suite 3400, Brunswick, ME 04011 Phone: 508-548-8989 Fax: 508-548-5789 |
Dr. Richard Beveridge, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 121 Medical Center Dr, Suite 3400, Brunswick, ME 04011 Phone: 207-406-7300 Fax: 207-406-7301 |
News Archive
As organizations that are committed to promoting accurate and appropriate evidence-based policies and practices to improve the quality of health care services in the United States, we are disappointed that the appointment today of 19 members to the Board of Governors for the new Patient-Centered Outcomes Research Institute (PCORI) includes only one Board member that directly represents patients.
In a new study researchers at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed a new kind of brain atlas based on an innovative method of mapping brain tissue into areas according to their molecular profile
Autism Speaks' Chief Science Officer Geraldine Dawson, Ph.D. emphasized the importance of research on environmental risk factors for autism spectrum disorders as the U.S. Senate Committee on Environment & Public Works, Subcommittee on Children's Health convened a special hearing on potential environmental health factors associated with autism spectrum disorders (ASD) and related neurodevelopmental disorders. The hearing is examining the latest research on potential environmental factors that may increase the risk for autism spectrum disorders.
Experts discussed the benefits of Home Monitoring technology from the perspective of patients, hospitals and payers for the first time at a press conference held by BIOTRONIK at the European Society of Cardiology's annual congress, ESC Congress 2014.
ChromoCure, Inc. (PINKSHEETS: KKUR) is pleased to announce the basis for the Company's technology confirmed by recent Mayo Clinic researchers. Their findings, which appear in the current issue of the journal Cancer Cell, along with an independent commentary on the discovery, end a major controversy in the field of cancer research as to whether aneuploidy is a cause or a consequence of cancer and further proves the aneuploidy basis of cancer.
› Verified 9 days ago